Fair Value Measurements and Financial Instruments (Tables)

12 Months Ended

Feb. 01, 2020

Fair Value of Assets and Liabilities Measured on a Recurring Basis

Our assets and liabilities measured at fair value on a recurring basis of February 1, 2020 and February 2, 2019 utilize Level 2 inputs and include the following (in millions):



	February 1, 2020		February 2, 2019
Assets:
Foreign currency contracts ⁽¹⁾	$	1.4	$	1.0
Company-owned life insurance⁽²⁾	4.1		14.6
Total assets	$	5.5	$	15.6
Liabilities:
Foreign currency contracts ⁽³⁾	$	0.3	$	1.2
Nonqualified deferred compensation⁽³⁾	1.0		1.1
Total liabilities	$	1.3	$	2.3

___________________


(1)	Recognized in prepaid expenses and other current assets in our consolidated balance sheets.


(2)	Recognized in other non-current assets in our consolidated balance sheets.


(3)	Recognized in accrued liabilities in our consolidated balance sheets.

Gains and Losses on Derivative Instruments and Foreign Currency Transaction

Activity related to the trading of derivative instruments and the offsetting impact of related intercompany loans denominated in foreign currencies recognized in selling, general and administrative expense is as follows (in millions):



	Fiscal Year
	2019			2018			2017
Gains (losses) on the changes in fair value of derivative instruments	$	4.1		$	9.6		$	(24.6	)
(Losses) gains on the re-measurement of related intercompany loans denominated in foreign currencies	(3.1		)	(6.6		)	27.0
Net gains	$	1.0		$	3.0		$	2.4